Clinical findings and treatments of granular corneal dystrophy type 2 (Avellino corneal dystrophy): A review of the literature

Eye and Contact Lens

Volumn 36, Issue 5, 2010, Pages 296-299

  Han, Kyung Eun ^a   Kim, Tae Im ^a   Chung, Woo Suk ^b   Choi, Seung Il ^a   Kim, Bong Yoon ^a   Kim, Eung Kweon ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b Siloan Eye Hospital   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Avellino corneal dystrophy; Exacerbation; Granular corneal dystrophy type 2; Surface ablation

Indexed keywords

MITOMYCIN C; PROTEIN; TRANSFORMING GROWTH FACTOR BETA INDUCED GENE PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 5; CORNEA DYSTROPHY; CORNEA INJURY; CORNEA OPACITY; DISEASE FREE INTERVAL; GENE MUTATION; GENOTYPE; GRANULAR CORNEAL DYSTROPHY TYPE 2; HUMAN; KERATECTOMY; KERATOMILEUSIS; KERATOPLASTY; LASER EPITHELIAL KERATOMILEUSIS; LENS IMPLANT; PENETRATING KERATOPLASTY; PHACOEMULSIFICATION; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; REFRACTIVE SURGERY; REVIEW; SURGICAL PATIENT; VISUAL ACUITY;

CHROMOSOMES, HUMAN, PAIR 5; CORNEA; CORNEAL DYSTROPHIES, HEREDITARY; CORNEAL TRANSPLANTATION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; KERATOMILEUSIS, LASER IN SITU; LENS IMPLANTATION, INTRAOCULAR; MITOMYCIN; MUTATION; PHACOEMULSIFICATION; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REFRACTIVE SURGICAL PROCEDURES; TRANSFORMING GROWTH FACTOR BETA;

EID: 77957588061     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e3181ef0da0     Document Type: Review

References (59)

1. Holland EJ, Daya SM, Stone E.M., et al. Avellino corneal dystrophy. Clinical manifestations and natural history. Ophthalmology 1992; 99: 1564-1568.
2. Ferry AP, Benson WH, Weinberg RS Combined granular-lattice ('Avellino') corneal dystrophy. Trans Am Ophthalmol Soc 1997; 95: 61-77.
3. Munier FL, Korvatska E, Djemai A., et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997; 15: 247-251.
4. Konishi M, Mashima Y, Nakamura Y., et al. Granular-lattice (Avellino) corneal dystrophy in Japanese patients. Cornea 1997; 16: 635-638.
5. El-Ashry M.F., Abd El-Aziz MM, Larkin DF, et al. A clinical, histopathological, and genetic study of Avellino corneal dystrophy in British families. Br J Ophthalmol 2003; 87: 839-842.
6. Banning CS, Kim WC, Randleman J.B., et al. Exacerbation of Avellino corneal dystrophy after LASIK in North America. Cornea 2006; 25: 482-484.
7. Rosenwasser GO, Sucheski BM, Rosa N, et al. Phenotypic variation in combined granular-lattice (Avellino) corneal dystrophy. Arch Ophthalmol 1993; 111: 1546-1552.
8. Akiya S, Takahashi H, Nakano N., et al. Granular-lattice (Avellino) corneal dystrophy. Ophthalmologica 1999; 213: 58-62.
9. Lee ES, Kim EK Surgical do's and don'ts of corneal dystrophies. Curr Opin Ophthalmol 2003; 14: 186-191.
10. Dighiero P, Ellies P, Valleix S., et al. [Avellino dystrophy. Current diagnostic criteria.] J Fr Ophtalmol 2000; 23: 735-737.
11. Streeten BW, Qi Y, Klintworth G.K., et al. Immunolocalization of beta ig-h3 protein in 5q31-linked corneal dystrophies and normal corneas. Arch Ophthalmol 1999; 117: 67-75.
12. Dunaief JL, Ng EW, Goldberg MF Corneal dystrophies of epithelial genesis: The possible therapeutic use of limbal stem cell transplantation. Arch Ophthalmol 2001; 119: 120-122.
13. Kocak-Altintas A.G., Kocak-Midillioglu I, Akarsu A.N., et al. BIGH3 gene analysis in the differential diagnosis of corneal dystrophies. Cornea 2001; 20: 64-68.
14. Kim HS, Yoon SK, Cho B.J., et al. BIGH3 gene mutations and rapid detection in Korean patients with corneal dystrophy. Cornea 2001; 20: 844-849.
15. Yu J, Zou LH, He J.C., et al. [Analysis of mutation of BIGH3 gene in Chinese patients with corneal dystrophies.] Zhonghua Yan Ke Za Zhi 2003; 39: 582-586.
16. Yamamoto S, Okada M, Tsujikawa M., et al. The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy. Cornea 2000; 19(3 SUPPL.): S21-S23.
17. Mashima Y, Yamamoto S, Inoue Y., et al. Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan. Am J Ophthalmol 2000; 130: 516-517.
18. Lee JH, Cristol SM, Kim W.C., et al. Prevalence of granular corneal dystrophy type 2 (Avellino corneal dystrophy) in the Korean population. Ophthalmic Epidemiol 2010; 17: 160-165.
19. Mashima Y, Konishi M, Nakamura Y., et al. Severe form of juvenile corneal stromal dystrophy with homozygous R124H mutation in the keratoepithelin gene in five Japanese patients. Br J Ophthalmol 1998; 82: 1280-1284.
20. Okada M, Yamamoto S, Inoue Y., et al. Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations. Invest Ophthalmol Vis Sci 1998; 39: 1947-1953.
21. Diaper CJ, Schorderet DF, Chaubert P, et al. Clinical and immunopathological corneal phenotype in homozygotes for the BIGH3 R124H mutation. Eye (Lond) 2005; 19: 92-96.
22. Moon JW, Kim SW, Kim T.I., et al. Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy): Natural history and progression after treatment. Cornea 2007; 26: 1095-1100.
23. Inoue T, Watanabe H, Yamamoto S., et al. Recurrence of corneal dystrophy resulting from an R124H Big-h3 mutation after phototherapeutic keratectomy. Cornea 2002; 21: 570-573.
24. Dogru M, Katakami C, Nishida T., et al. Alteration of the ocular surface with recurrence of granular/Avellino corneal dystrophy after phototherapeutic keratectomy: Report of five cases and literature review. Ophthalmology 2001; 108: 810-817.
25. Park SH, Mok J, Joo C.K., et al. Heterozygous Avellino corneal dystrophy 9 years after photorefractive keratectomy: Natural or laser-induced accelerated course? Cornea 2009; 28: 465-467.
26. Kim TI, Kim T, Kim S.W., et al. Comparison of corneal deposits after LASIK and PRK in eyes with granular corneal dystrophy type II. J Refract Surg 2008; 24: 392-395.
27. Wan XH, Lee HC, Stulting R.D., et al. Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea 2002; 21: 223-226.
28. Jun RM, Tchah H, Kim T.I., et al. Avellino corneal dystrophy after LASIK. Ophthalmology 2004; 111: 463-468.
29. Roh MI, Grossniklaus HE, Chung S.H., et al. Avellino corneal dystrophy exacerbated after LASIK: Scanning electron microscopic findings. Cornea 2006; 25: 306-311.
30. Aldave AJ, Sonmez B, Forstot S.L., et al. A clinical and histopathologic examination of accelerated TGFBIp deposition after LASIK in combined granular-lattice corneal dystrophy. Am J Ophthalmol 2007; 143: 416-419.
31. Chiu EK, Lin AY, Folberg R, et al. Avellino dystrophy in a patient after laser-assisted in situ keratomileusis surgery manifesting as granular dystrophy. Arch Ophthalmol 2007; 125: 703-705.
32. Lee WB, Himmel KS, Hamilton S.M., et al. Excimer laser exacerbation of Avellino corneal dystrophy. J Cataract Refract Surg 2007; 33: 133-138.
33. Awwad ST, Di Pascuale MA, Hogan RN, et al. Avellino corneal dystrophy worsening after laser in situ keratomileusis: Further clinicopathologic observations and proposed pathogenesis. Am J Ophthalmol 2008; 145: 656-661.
34. Lee JH, Stulting RD, Lee D.H., et al. Exacerbation of granular corneal dystrophy type II (Avellino corneal dystrophy) after LASEK. J Refract Surg 2008; 24: 39-45.
35. Kim TI, Roh MI, Grossniklaus H.E., et al. Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK. Cornea 2008; 27: 28-32.
36. Kaji Y, Soya K, Amano S., et al. Relation between corneal haze and transforming growth factor-beta1 after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 2001; 27: 1840-1846.
37. Roh MI, Chung SH, Stulting R.D., et al. Preserved peripheral corneal clarity after surgical trauma in patients with Avellino corneal dystrophy. Cornea 2006; 25: 497-498.
38. Stark WJ, Chamon W, Kamp M.T., et al. Clinical follow-up of 193-nm ArF excimer laser photokeratectomy. Ophthalmology 1992; 99: 805-812.
39. Mannis MJ, De Sousa L, Gross RH The Stromal Dystrophies: Cornea. St. Louis, CV Mosby, 1997.
40. Nassaralla BA, Garbus J, McDonnell PJ Phototherapeutic keratectomy for granular and lattice corneal dystrophies at 1.5 to 4 years. J Refract Surg 1996; 12: 795-800.
41. Orndahl MJ, Fagerholm PP Treatment of corneal dystrophies with phototherapeutic keratectomy. J Refract Surg 1998; 14: 129-135.
42. Dinh R, Rapuano CJ, Cohen E.J., et al. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology 1999; 106: 1490-1497.
43. Marcon AS, Rapuano CJ Excimer laser phototherapeutic keratectomy retreatment of anterior basement membrane dystrophy and Salzmann's nodular degeneration with topical mitomycin C. Cornea 2002; 21: 828-830.
44. Azar DT, Jain S. Topical MMC for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2001; 108: 239-240.
45. Miller A, Solomon R, Bloom A., et al. Prevention of recurrent Reis-Bucklers dystrophy following excimer laser phototherapeutic keratectomy with topical mitomycin C. Cornea 2004; 23: 732-735.
46. Majmudar PA, Forstot SL, Dennis R.F., et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000; 107: 89-94.
47. Maldonado MJ. Intraoperative MMC after excimer laser surgery for myopia. Ophthalmology 2002; 109: 826; author reply 826-828.
48. Porges Y, Ben-Haim O, Hirsh A., et al. Phototherapeutic keratectomy with mitomycin C for corneal haze following photorefractive keratectomy for myopia. J Refract Surg 2003; 19: 40-43.
49. Frucht-Pery J., Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994; 117: 164-168.
50. Singh G, Wilson MR, Foster CS Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988; 95: 813-821.
51. Bergstrom TJ, Wilkinson WS, Skuta G.L., et al. The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits. Arch Ophthalmol 1991; 109: 1725-1730.
52. Kim TI, Pak JH, Chae J.B., et al. Mitomycin C inhibits recurrent Avellino dystrophy after phototherapeutic keratectomy. Cornea 2006; 25: 220-223.
53. Ha BJ, Kim TI, Choi S.I., et al. Mitomycin C does not inhibit exacerbation of granular corneal dystrophy type ii induced by refractive surface ablation. Cornea 2010; 29: 490-496.
54. Kim TI, Choi SI, Lee H.K., et al. Mitomycin C induces apoptosis in cultured corneal fibroblasts derived from type II granular corneal dystrophy corneas. Mol Vis 2008; 14: 1222-1228.
55. Kim E-K, Cho H-J, Ahn S-Y, et al. Lysosomal traffic and degradation of {beta}ig-h3 protein. Invest Ophthalmol Vis Sci 2007; 48: 5864.
56. Lee JH, Chung SH, Stulting R.D., et al. Effects of corneal neovascularization on the manifestations of Avellino corneal dystrophy (granular corneal dystrophy type II). Cornea 2006; 25: 914-918.
57. Skonier J, Bennett K, Rothwell V., et al. Beta ig-h3: A transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994: 13: 571-584.
58. Thapa N, Lee BH, Kim IS TGFBIp/betaig-h3 protein: A versatile matrix molecule induced by TGF-beta. Int J Biochem Cell Biol 2007; 39: 2183-2194.
59. Choi SI, Kim TI, Kim K.S., et al. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol 2009; 175: 248-261.